Céline Sarr
About
In The Last Decade
Céline Sarr
13 papers receiving 370 citations
Peers
Comparison fields: 5 of 71
- Molecular Biology 156
- Oncology 128
- Pulmonary and Respiratory Medicine 119
- Cancer Research 95
- Modeling and Simulation 70
Countries citing papers authored by Céline Sarr
This map shows the geographic impact of Céline Sarr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Céline Sarr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Céline Sarr more than expected).
Fields of papers citing papers by Céline Sarr
This network shows the impact of papers produced by Céline Sarr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Céline Sarr. The network helps show where Céline Sarr may publish in the future.
Co-authorship network of co-authors of Céline Sarr
This figure shows the co-authorship network connecting the top 25 collaborators of Céline Sarr. A scholar is included among the top collaborators of Céline Sarr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Céline Sarr. Céline Sarr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 3 | |
| 3 | 1 | |
| 4 | 12 | |
| 5 | 26 | |
| 6 | 151 | |
| 7 | 134 | |
| 8 | Hyperglycemia in patients treated with the pan-PI3K inhibitor buparlisib (BKM120): characterization, management, and assessment for pharmacodynamics | 1 |
| 9 | 33 | |
| 10 | 4 | |
| 11 | 4 | |
| 12 | 2 | |
| 13 | 2 | |
| 14 | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.